Award

Delivery Order #SPE2DR26FSMJ3

Delivery Order for XOLAIR Syringes Under Existing IDV Contract

Buyer

Defense Logistics Agency

Award Amount

$3,778.64

Ceiling

$3,778.64

Awarded

February 26, 2026

Period of Performance

Feb 26, 2026 – Mar 19, 2026

Identifier

SPE2DR26FSMJ3

NAICS

424210

This award represents a delivery order contract for pharmaceutical products, specifically XOLAIR 300 MG/2 ML syringes. The recipient is DMS Pharmaceutical Group Inc., a company specializing in pharmaceutical distribution, operating under an existing indefinite delivery vehicle (IDV) contract with the government. The products procured consist of syringes used for medical treatment, supporting ongoing public health objectives. This delivery order is significant as it ensures timely access to essential medications within an established procurement framework, thereby maintaining supply chain continuity. The scope of work includes the supply and delivery of these syringes to the specified location in Park Ridge, Illinois, over a short-term performance period spanning a few weeks in early 2026. The contract follows from a previously awarded IDV contract that was competitively bid, reflecting established vendor relationships and adherence to acquisition protocols. This award contributes to the broader pharmaceutical acquisition program aimed at sustaining vital healthcare provisions.

Description

4571044850!XOLAIR 300 MG/2 ML SYRINGE 2ML

View original record